SHANGHAI, May 30, 2024 /PRNewswire/ -- On May 23, OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the 'Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases' (hereinafter referred to as the 'Clinical Evaluation and Translation Center') at the 2024 Global Rare Disease Research Symposium and the 2nd China Rare Disease Research and Translational Medicine Conference.

上海，2024年5月30日/新华社/--5月23日，世界领先的细胞和基因治疗合同开发和制造组织OBiO Technology在2024年全球罕见病研究研讨会和第二届中国罕见病研究与转化医学会议上正式启动了“儿科罕见病和遗传病先进疗法临床评估与翻译中心”（以下简称“临床评估与翻译中心”）。

This center, jointly initiated by Shanghai Children's Medical Center, Zhejiang Hope for Rare Foundation, and OBiO Technology aimed to promote clinical research and therapeutic innovation for pediatric rare and genetic diseases..

该中心由上海儿童医学中心、浙江希望稀有基金会和OBiO技术联合发起，旨在促进儿科罕见病和遗传病的临床研究和治疗创新。。

Continue Reading

继续阅读

Launch Ceremony Highlights

启动仪式亮点

Mr. Houjia Liu, Director of the Shanghai Biomedical Industry Promotion Center, delivered the opening speech. Representing the Shanghai Biomedical Industry Promotion Center, Mr. Liu extended warm congratulations on the establishment of the Clinical Evaluation and Translation Center. He praised its significant role in advancing pediatric rare disease diagnosis and treatment and emphasized Shanghai's strategic planning and policy support for the bio-pharmaceutical industry..

上海生物医药产业促进中心主任刘侯佳先生致开幕词。刘先生代表上海生物医学产业促进中心对临床评估与翻译中心的成立表示热烈祝贺。他赞扬其在推进儿科罕见病诊断和治疗方面的重要作用，并强调了上海对生物制药行业的战略规划和政策支持。。

Ms. Wei Zhu, Deputy Director of the Shanghai Pudong New Area Health Commission, also spoke enthusiastically, expressing strong support and congratulations on behalf of her commission. She expressed strong support and congratulations on the establishment of the 'Clinical Evaluation and Translation Center', highlighted the development plan for healthcare in Pudong New Area and reaffirmed their commitment to improving medical services and advancing research in rare disease treatment.

上海市浦东新区卫生委员会副主任朱伟女士也热情发言，代表浦东新区卫生委员会表示大力支持和祝贺。她对“临床评估和翻译中心”的成立表示强烈支持和祝贺，强调了浦东新区医疗保健的发展计划，并重申了他们对改善医疗服务和推进罕见病治疗研究的承诺。

Both leaders' speeches added gravity and grandeur to the event, setting a clear direction for the center's future, showing strong support for the pediatric rare disease treatment.At the signing ceremony, Ms. Li Hong, Vice President of Shanghai Children's Medical Center, Mr. Oudong Pan, Founder & Chairman of OBiO Technology Co., Ltd., and Mr.

两位领导人的讲话为这一活动增添了庄重和庄严，为该中心的未来指明了方向，显示出对儿科罕见病治疗的强烈支持。在签约仪式上，上海儿童医疗中心副总裁李红女士、奥比奥科技有限公司创始人兼董事长欧东潘先生和。

Tao Duan, Co-founder of Hope for Rare Foundation, signed a cooperation agreement, marking the official establishment of the Clinical Evaluation and Translation Center.Open Cooperation PlatformThe Clinical Evaluation and Translation Center is an open platform welcoming enterprises, universities, research institutes, foundations, and individuals involved in advanced therapies.

希望稀有基金会联合创始人陶端签署了合作协议，标志着临床评估和翻译中心正式成立。开放合作平台临床评估和翻译中心是一个开放平台，欢迎参与先进疗法的企业，大学，研究机构，基金会和个人。

The center aims to leverage regional policy advantages to build a cell and gene therapy industry cooperation platform, focusing on technological R&D innovation, clinical application, industry-academia-research cooperation, resource sharing, and collaborative innovation to enhance the technological and industrial competitiveness of cell and gene therapy.Ms.

该中心旨在利用区域政策优势，构建细胞和基因治疗产业合作平台，重点关注技术研发创新、临床应用、产学研合作、资源共享和协同创新，提升细胞和基因治疗的技术和产业竞争力。女士。

Li Hong delivered the speech titled 'Practice Mission, Bravely Undertake the Leadership Responsibility of Pediatric Rare Disease Diagnosis and Treatment,' emphasizing Shanghai Children's Medical Center's leadership and commitment in .

李红发表了题为“实践使命，勇敢承担儿科罕见病诊疗的领导责任”的演讲，强调了上海儿童医学中心在年的领导和承诺。